Generation of mycobacterial lipoarabinomannan-specific monoclonal antibodies and their ability to identify mycobacterium isolates
Zhuo-Hong Yan,Bing Zhao,Yu Pang,Xiao-Jue Wang,Ling Yi,He-Lin Wang,Bin Yang,Pan-Jian Wei,Hong-Yan Jia,Shu-Ping Li,Yan-Lin Zhao,Hong-Tao Zhang
DOI: https://doi.org/10.1016/j.jmii.2020.02.005
2021-06-01
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background/Purpose</h3><p>The World Health Organization has recommended commercial urine-sourced lipoarabinomannan (LAM) detection as a tool for screening HIV patients with suspected TB, but more sensitive immunodetection assays would help to identify HIV-negative TB patients. Here, we aimed to develop novel rabbit monoclonal antibodies (mAbs) against LAM for immunodetection purposes.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>Rabbits were immunized with cell-wall components from the <em>Mycobacterium tuberculosis</em> (Mtb) <em>H37Rv</em> strain, an immune single-chain fragment variable (scFv) phage display library was generated, and the scFv mAbs produced were bound to purified LAM from <em>H37Rv</em> before isolation. The light and heavy chain variable region genes from the selected clones were sequenced, and the full-length light and heavy chains were cloned into vector pCMV3, and then co-expressed in 293 T cells to generate whole IgG antibodies. The performances and binding characteristics of the mAbs against purified LAM from <em>M.tb H37Rv</em>, multiple mycobacteria species (<em>M.tb H37Rv</em>, <em>M. bovis</em> and non-tuberculous mycobacteria (NTM) strains), and clinical mycobacteria isolates (Mtb and NTM isolates) were determined using various immunoassay methods.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>We obtained five rabbit mAbs against LAM, four of which had high sensitivities (100 pg/ml) and affinities (1.16 to 1.73×10<sup>-9</sup> M) towards LAM, and reacted with <em>M.tb H37Rv</em>, <em>M. bovis,</em> and slow-growing NTM, but not with rapid-growing NTM. Similar results were obtained with mycobacterium isolates, where 96% of the Mtb isolates and 90% of the <em>M. avium</em>-intracellulare isolates were successfully identified.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>Our novel rabbit LAM-specific mAbs performed well at recognizing LAM from slow-growing pathogenic mycobacteria, supporting their future diagnostic potential.</p>
immunology,infectious diseases,microbiology